RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Clinical trials for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study tests an experimental cell therapy called LUCAR-DKS1 in 36 adults whose autoimmune diseases (like lupus or vasculitis) have not responded to standard treatments. The main goals are to check safety and find the right dose. Researchers will monitor side effec…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated May 17, 2026 12:57 UTC
-
New cell therapy trial offers hope for tough autoimmune cases
Disease control Recruiting nowThis study tests a new treatment called LUCAR-G79 for people with autoimmune diseases like lupus that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified to target and attack disease-causing cells. The goal is to see if it is safe a…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Immune reset: CAR-T therapy shows promise for autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, called CAR-T cells, to fight severe autoimmune diseases that haven't responded to other therapies. The treatment targets a protein called CD19 on immune cells to help reset the immune system. Early results from …
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: NA • Sponsor: ShenZhen Cell Valley • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New injection aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug, AFN50, in 18 adults with autoimmune diseases that haven't responded to other treatments. The main goal is to check if the drug is safe and tolerable. Researchers will also measure how long special immune cells (CAR T cells) stay in the blo…
Matched conditions: RELAPSED/REFRACTORY AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC